Tom Taghon 1 – 1 of 1 publication Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Filter publications Download search results Subscribe to news feed Add to list Journal Article A1 open access Tet2 is a tumor suppressor in the pre-leukemic phase of T-cell acute lymphoblastic leukemia Stien De Coninck, Juliette Roels (UGent) , Béatrice Lintermans (UGent) , Sara T'Sas (UGent) , Tom Taghon, David Curtis, Tim Pieters (UGent) , Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent) (2024) BLOOD ADVANCES. 8(11). p.2646-2649
